Senior insider sale
General Counsel at NURIX THERAPEUTICS, INC. — senior position signals high conviction
$1.50M
72.83K shares
RING CHRISTINE plans to sell 72.83K shares of NURIX THERAPEUTICS, INC. valued at approximately $1.50M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
Restricted Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/3/2026 | Exercise of Stock Options Cash | 5.79K | — |
7/30/2025 | Restricted Stock Units N/A | 10.80K | — |
| Total | 16.59K | ||
Completed
Units to sell
5.79K
Market value
$136.3K
Units to sell
5.22K
Market value
$123.0K
Units to sell
28.93K
Market value
$580.5K
Units to sell
8.15K
Market value
$135.3K
Units to sell
4.78K
Market value
$81.1K
Units to sell
3.37K
Market value
$57.1K
Planned — Approximate Date
Units to sell
16.59K
Market value
$385.0K
Units
72.83K
Value
$1.50M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/2/2026 | 5.79K | $136.3K | — | Completed |
7/2/2026 | 5.22K | $123.0K | — | Completed |
6/25/2026 | 28.93K | $580.5K | — | Completed |
6/2/2026 | 8.15K | $135.3K | — | Completed |
5/4/2026 | 4.78K | $81.1K | — | Completed |
5/4/2026 | 3.37K | $57.1K | — | Completed |
| Planned — Approximate Date | ||||
8/3/2026 | 16.59K | $385.0K | NASDAQ | Planned |
| Total | 72.83K | $1.50M | ||